SGTSY yields 200.00% · PFE yields 6.13%● Live data
📍 SGTSY pulled ahead of the other in Year 1
Combined, SGTSY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SGTSY + PFE for your $10,000?
Singulus Technologies AG, together with its subsidiaries, develops, builds, and sells machinery in the areas of vacuum deposition, surface engineering, wet chemical, and thermal processing technologies worldwide. The company operates through three segments: Solar, Life Science, and Semiconductor. The Solar segment develops production solutions to manufacture solar cell concepts, including heterojunction, interdigitated back contact, and tunnel oxide passivated contacts for crystalline and thin-film solar cells. The Life Science segment offers product solutions for medical technology, decorative coating, and data storage; and develops an integrated product line DECOLINE II, inline vacuum cathode sputtering machine POLYCOATER, and MEDLINE for application in medical technologies. This segment also provides data storage machines for the production of optical disc formats comprising of CD, DVD, dual layer Blu-ray, and Ultra HD Blu-ray discs. The Semiconductor segment supplies special purpose machines and machine platforms, such as TIMARIS and ROTARIS for use in magneto resistive random access memory, sensors, power controllers, and microelectromechanical systems. Singulus Technologies AG was founded in 1995 and is headquartered in Kahl am Main, Germany.
Full SGTSY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.